We are live on ! Find out more
BOCH

Blue Owl Capital Holdings Portfolio holdings

AUM $372M
1-Year Est. Return 78.25%
This Fund
S&P 500
This Quarter Est. Return
-2.91%
1 Year Est. Return
+78.25%
3 Year Est. Return
+112.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$434M
AUM Growth
-$84.4M
Cap. Flow
-$38.8M
Cap. Flow %
-8.93%
Top 10 Hldgs %
71.48%
Holding
147
New
10
Increased
10
Reduced
15
Closed
68

Top Buys

Rank Stock Value
1
CNDT icon
Conduent
CNDT
+$8.99M
2
TNGX icon
Tango Therapeutics
TNGX
+$8.04M
3
ELDN icon
Eledon Pharmaceuticals
ELDN
+$7.73M
4
KROS icon
Keros Therapeutics
KROS
+$6.24M
5
EYPT icon
EyePoint Inc
EYPT
+$6.21M

Top Sells

Rank Stock Value
1
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$23.6M
2
TRML
Tourmaline Bio
TRML
+$11.4M
3
LNZA icon
LanzaTech
LNZA
+$5.59M
4
CCC
CCC Intelligent Solutions
CCC
+$5.05M
5
STWD icon
Starwood Property Trust
STWD
+$4.62M

Sector Composition

Rank Sector Weight
1 Healthcare 50.71%
2 Financials 25.62%
3 Technology 21%
4 Consumer Discretionary 2.08%
5 Energy 0.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
26
DELISTED
Centessa Pharmaceuticals
CNTA
$3.69M 0.85%
220,000
-35,000
-14% -$580K
AQST icon
27
Aquestive Therapeutics
AQST
$494M
$3.2M 0.74%
900,000
-325,000
-27% -$1.5M
PVLA
28
Palvella Therapeutics
PVLA
$2.27B
$3M 0.69%
+250,062
New +$3.93M
INZY
29
DELISTED
Inozyme Pharma
INZY
$2.99M 0.69%
1,080,027
-40,000
-4% -$152K
MREO
30
Mereo BioPharma
MREO
$47.3M
$2.35M 0.54%
672,809
-175,000
-21% -$688K
MRKR icon
31
Marker Therapeutics
MRKR
$18.7M
$1.72M 0.4%
+554,250
New +$1.96M
AEON icon
32
AEON Biopharma
AEON
$13.5M
$1.65M 0.38%
42,352
-4,054
-9% -$236K
ADCT icon
33
ADC Therapeutics
ADCT
$144M
$1.46M 0.34%
733,568
– –
EPD icon
34
Enterprise Products Partners
EPD
$81.7B
$981K 0.23%
31,290
– –
OMGA
35
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$787K 0.18%
1,055,882
– –
SHFS icon
36
SHF Holdings
SHFS
$1.13M
$683K 0.16%
75,896
– –
RZLV
37
Rezolve AI
RZLV
$1.09B
$670K 0.15%
+181,667
New +$749K
GATE
38
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$638K 0.15%
91,429
– –
CMPS
39
Compass Pathways
CMPS
$1.83B
$609K 0.14%
+161,238
New +$818K
GTLB icon
40
GitLab
GTLB
$6.58B
$568K 0.13%
+10,076
New +$587K
ROIV icon
41
Roivant Sciences
ROIV
$26.2B
$461K 0.11%
39,003
– –
RZLVW
42
Rezolve AI Warrants
RZLVW
$5.64M
$447K 0.1%
603,429
– –
PLMJW
43
DELISTED
Plum Acquisition Corp. III Warrant
PLMJW
$220K 0.05%
1,166,665
– –
SLND.WS icon
44
Southland Holdings Warrants
SLND.WS
$206K 0.05%
860,302
– –
CAH icon
45
Cardinal Health
CAH
$55.4B
$203K 0.05%
1,718
– –
OPTX icon
46
Syntec Optics
OPTX
$314M
$125K 0.03%
+49,575
New +$75.3K
AMODW
47
Alpha Modus Holdings Warrant
AMODW
$316K
$95K 0.02%
1,187,999
– –
PLMJU
48
DELISTED
Plum Acquisition Corp. III Unit
PLMJU
$94.6K 0.02%
15,000
– –
OPTXW icon
49
Syntec Optics Holdings Warrant
OPTXW
$19.2M
$88.3K 0.02%
803,132
– –
SATX
50
DELISTED
SatixFy Communications
SATX
$77.7K 0.02%
50,794
– –
1
2
3 4 5

Similar funds

PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
GIP
Gavilan Investment Partners Burlingame, California $372M AUM 6.04% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return
JC
Joho Capital New York $373M AUM 18.89% 1-Year Est. Return

Blue Owl Capital Holdings's Q4 2024 Portfolio in Review

As of Q4 2024, Blue Owl Capital Holdings held 147 positions worth $434M, down 16% from $518M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Blue Owl Capital Holdings withdrew a net $38.8M in Q4 2024, closing 68 positions and reducing 15 holdings. Its most notable exit was ProShares UltraPro QQQ, an estimated $23.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 53% a quarter earlier, followed by Financials and Technology.

Against the trend, Blue Owl Capital Holdings opened a new position in Tango Therapeutics worth $5.35M.

  • Blue Owl Capital Holdings's largest Q4 2024 buy was Tango Therapeutics: 1,732,152 shares worth $5.35M.
  • Blue Owl Capital Holdings added most to Conduent in Q4 2024, an estimated $8.99M increase.
  • Blue Owl Capital Holdings's biggest Q4 2024 reduction was Tourmaline Bio, cutting an estimated $11.4M.
  • Blue Owl Capital Holdings fully exited ProShares UltraPro QQQ in Q4 2024, selling an estimated $23.6M.
  • Blue Owl Capital Holdings's ten largest holdings make up 71% of its $434M portfolio in Q4 2024.
  • Blue Owl Capital Holdings opened 10 new positions and closed 68 in Q4 2024.
  • Blue Owl Capital Holdings's portfolio value fell 16% quarter-over-quarter to $434M.

Based on Blue Owl Capital Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.